The following stories appear in full on today's Vidyya Medical News Service Web site.
Earlier this week, Vidyya reported that the Ebola virus had claimed one of it's most valiant fighters. The epidemic continues, though at a slower pace than in previous months. The cumulative figure for all affected districts in Uganda is 405 cases and 160 deaths.
For more information: Ebola Update: 405 Cases 160 Deaths
The World Health Organization (WHO) and the Open Society Institute (OSI), a part of the Soros Foundation network, have teamed up with leading information providers ISIŅ and SilverPlatter and other public and private partners to provide access to high quality scientific information, via the Internet, to research centres in countries in Africa, Central Asia and Eastern Europe. Discussions are also under way with Elsevier Science to join the initiative.
For more information: "Life-Saving" Scientific Information Boost Via Internet To Health Researchers In Africa, Central Asia And Eastern Europe
A malaria epidemic that has already affected an estimated 276,000 people in the northern highland districts of Burundi could affect hundreds of thousands more with the imminent rainy season, the Roll Back Malaria (RBM) secretariat at the World Health Organization (WHO) warns today. RBM partners have organized urgent shipments of drugs to the central African country to treat those affected by the epidemic which is thought to have been sparked by October rains.
For more information: Rain Fears As Malaria Epidemic Hits Burundi
The latest report from the Age-Related Eye Disease Study (AREDS) in the December issue of Ophthalmology, the journal of the American Academy of Ophthalmology, emphasizes the association of smoking and hypertension with development of macular degeneration. The study also calls for further investigation of the apparent association between antacid and thyroid hormone use and macular degeneration.
For more information: Macular Degeneration Associated With Smoking, Hypertension And Antacid Use
Britain's SmithKline Beecham PLC, the maker of the popular anti-depressant Paxil, is facing a federal investigation into whether it violated antitrust laws by preventing or impeding the marketing of generic equivalents. The investigation was revealed this week in court documents filed in federal court in Chicago by Apotex Corp., which is trying to market a generic version of Paxil.
For more information: Federal Inquiry In The Works For Paxil Maker
Today's Vidyya articles are:
As always, we hope you enjoy the issue.